Company Info
Phone(866) 725-0930
Year Established
2011
Ticker
LONA
Exchange
NASDAQ
Contacts
Mark Litton, Ph.D., M.B.A.President & CEO
Robert Renninger
CFO
Mark Worthington, JD
General Counsel
Kevin Church, PhD
CSO
Javier San Martin, M.D.
CMO
Company Description
LeonaBio, formerly Athira Pharma & M3 Biotechnology, a clinical-stage biopharmaceutical company dedicated to the development of novel therapeutics for high unmet medical needs, including treatment-resistant metastatic breast cancer and amyotrophic lateral sclerosis (ALS), with the goal of improving patients’ lives.